PHAGERIA Trademark

Trademark Overview


On Tuesday, June 29, 2021, a trademark application was filed for PHAGERIA with the United States Patent and Trademark Office. The USPTO has given the PHAGERIA trademark a serial number of 90800590. The federal status of this trademark filing is REGISTERED as of Tuesday, October 10, 2023. This trademark is owned by iNtRON Biotechnology, Inc.. The PHAGERIA trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

research and development relating to drug substance and drug products for the pharmaceutical, biotech and vaccine sectors; evaluation relating to drug substance and drug products for the pharmaceutical, biotech and vaccine sectors; consultancy relating to drug substance and drug products for the pharmaceutical, biotech and vaccine sectors; testing relating to drug substance and drug products for the pharmaceutical, biotech and vaccine sectors; research and development of pharmaceutical, biotech and vaccine products; consultancy relating to pharmaceutical, biotech and vaccine sectors; advisory services relating to research and development of pharmaceutical, biotech and vaccine products
phageria

General Information


Serial Number90800590
Word MarkPHAGERIA
Filing DateTuesday, June 29, 2021
Status700 - REGISTERED
Status DateTuesday, October 10, 2023
Registration Number7185611
Registration DateTuesday, October 10, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 25, 2023

Trademark Statements


Goods and Servicesresearch and development relating to drug substance and drug products for the pharmaceutical, biotech and vaccine sectors; evaluation relating to drug substance and drug products for the pharmaceutical, biotech and vaccine sectors; consultancy relating to drug substance and drug products for the pharmaceutical, biotech and vaccine sectors; testing relating to drug substance and drug products for the pharmaceutical, biotech and vaccine sectors; research and development of pharmaceutical, biotech and vaccine products; consultancy relating to pharmaceutical, biotech and vaccine sectors; advisory services relating to research and development of pharmaceutical, biotech and vaccine products

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, September 10, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameiNtRON Biotechnology, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSungnam-si, Kyeonggi-d 462-120
KR

Party NameiNtRON Biotechnology, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSungnam-si, Kyeonggi-d 462-120
KR

Party NameiNtRON Biotechnology, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSungnam-si, Kyeonggi-d 462-120
KR

Trademark Events


Event DateEvent Description
Tuesday, October 10, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, October 10, 2023REGISTERED-PRINCIPAL REGISTER
Tuesday, July 25, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 25, 2023PUBLISHED FOR OPPOSITION
Wednesday, July 5, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 20, 2023LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, June 13, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, June 13, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, June 13, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, June 9, 2023TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Friday, April 14, 2023NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Friday, April 14, 2023LETTER OF SUSPENSION E-MAILED
Friday, April 14, 2023SUSPENSION LETTER WRITTEN
Thursday, April 13, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, April 13, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, April 13, 2023ASSIGNED TO LIE
Wednesday, January 18, 2023TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Thursday, August 4, 2022NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Thursday, August 4, 2022INQUIRY TO SUSPENSION E-MAILED
Thursday, August 4, 2022SUSPENSION INQUIRY WRITTEN
Friday, July 8, 2022SUSPENSION CHECKED ¿ TO ATTORNEY FOR ACTION
Tuesday, December 21, 2021NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, December 21, 2021LETTER OF SUSPENSION E-MAILED
Tuesday, December 21, 2021SUSPENSION LETTER WRITTEN
Friday, December 17, 2021ASSIGNED TO EXAMINER
Friday, September 10, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, July 2, 2021NEW APPLICATION ENTERED